Keiji Furuuchi

Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer

Yukiko Tone, Keiji Furuuchi, Yoshitsugu Kojima et al. · Nature Immunology · 2007 · 786 citations

Life Sciences, Genetics, Molecular Biology +8

Gelsolin: a candidate for suppressor of human bladder cancer.

Motoyoshi Tanaka, Leonhard Müllauer, Yoshifumi Ogiso et al. · PubMed · 1995 · 187 citations · Full text

Medicine, Molecular Biology, Oncology +12

Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.

Hajime Takayasu, Hiroshi Horie, Eiso Hiyama et al. · PubMed · 2001 · 135 citations

Medicine, Genetics, Oncology +16

First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori et al. · Clinical Cancer Research · 2021 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

Xin Cheng, Jing Li, Keigo Tanaka et al. · Molecular Cancer Therapeutics · 2018 · 92 citations

Medicine, Oncology, Pharmacology +16